Literature DB >> 14670298

Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation.

Benjamin J McFarland1, Roland K Strong.   

Abstract

The homodimeric immunoreceptor NKG2D drives the activation of effector cells following engagement of diverse, conditionally expressed MHC class I-like protein ligands. NKG2D recognition is highly degenerate in that a single surface on receptor monomers binds pairs of distinct surfaces on each structurally divergent ligand, simultaneously accommodating multiple nonconservative ligand allelic or isoform substitutions. In contrast to TCR-pMHC and other NK receptor-ligand interactions, thermodynamic and kinetic analyses of four NKG2D-ligand pairs (MIC-A*001, MIC-B*005, ULBP1, and RAE-1beta) reported here show that the relative enthalpic and entropic terms, heat capacity, association rates, and activation energy barriers are comparable to typical, rigid protein-protein interactions. Rather than "induced-fit" binding, NKG2D degeneracy is achieved using distinct interaction mechanisms at each rigid interface.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670298     DOI: 10.1016/s1074-7613(03)00320-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  31 in total

Review 1.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Systematic mutation and thermodynamic analysis of central tyrosine pairs in polyspecific NKG2D receptor interactions.

Authors:  David J Culpepper; Michael K Maddox; Andrew B Caldwell; Benjamin J McFarland
Journal:  Mol Immunol       Date:  2010-11-12       Impact factor: 4.407

Review 3.  Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

Review 4.  Polyspecificity of T cell and B cell receptor recognition.

Authors:  Kai W Wucherpfennig; Paul M Allen; Franco Celada; Irun R Cohen; Rob De Boer; K Christopher Garcia; Byron Goldstein; Ralph Greenspan; David Hafler; Philip Hodgkin; Erik S Huseby; David C Krakauer; David Nemazee; Alan S Perelson; Clemencia Pinilla; Roland K Strong; Eli E Sercarz
Journal:  Semin Immunol       Date:  2007-03-29       Impact factor: 11.130

5.  NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors.

Authors:  Claire Godbersen; Tiffany A Coupet; Amelia M Huehls; Tong Zhang; Michael B Battles; Jan L Fisher; Marc S Ernstoff; Charles L Sentman
Journal:  Mol Cancer Ther       Date:  2017-05-12       Impact factor: 6.261

6.  Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion.

Authors:  Rui Wang; Kannan Natarajan; Maria Jamela R Revilleza; Lisa F Boyd; Li Zhi; Huaying Zhao; Howard Robinson; David H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

7.  Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.

Authors:  Roberto Biassoni; Elisabetta Ugolotti; Andrea De Maria
Journal:  Self Nonself       Date:  2010-03-06

8.  Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).

Authors:  Jun Kamishikiryo; Hideo Fukuhara; Yuki Okabe; Kimiko Kuroki; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

Review 9.  The molecular basis of TCR germline bias for MHC is surprisingly simple.

Authors:  K Christopher Garcia; Jarrett J Adams; Dan Feng; Lauren K Ely
Journal:  Nat Immunol       Date:  2009-02       Impact factor: 25.606

10.  Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands.

Authors:  Steffen Müller; Georg Zocher; Alexander Steinle; Thilo Stehle
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.